$Amazing $Biotech & $olid $Microcap $tocks

[ash111]

CBLI, that's $20+ stock if you ask me, https://www.streetinsider.com/Corporate+News/Cleveland+Biolabs+%28CBLI%29+Receives+EMA+Positive+Opinion+Regarding+Entolimod+Pediatric+Investigation+Plan/12781446.html

w/strong Cash on Hand and Solid balance sheet. company has no l.t debt, last 10-k: $15m cash and only 3m liabilities. also backup by both Russian Federation Ministry of Industry and FDA. Europe +Asia Market way larger than U.S Market.

"The market for medical radiation countermeasures grew dramatically following the September 11, 2001 terrorist attacks and the subsequent use of anthrax in a biological attack in the U.S. Terrorist activities worldwide have continued in the intervening years and the possibility of chemical, biological, radiation and nuclear attacks continues to represent a perceived threat for governments world-wide. In addition to the U.S. government, which maintains a national stockpile of products for emergency use (the " National Stockpile "), we believe the potential markets for the sale of radiation countermeasures include U.S. federal, state and local governments, including defense and public health agencies; foreign governments; non-governmental organizations; multinational corporations; transportation and security companies; healthcare providers; and, nuclear power facilities"..